Allianz Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.7M | Buy |
48,445
+10,697
| +28% | +$6.02M | 0.02% | 616 |
|
|
2026
Q1 | $22.4M | Buy |
37,748
+14,244
| +61% | +$7.09M | 0.02% | 583 |
|
|
2025
Q4 | $11.5M | Sell |
23,504
-21,568
| -48% | -$10M | 0.01% | 802 |
|
|
2025
Q3 | $18.9M | Sell |
45,072
-19,018
| -30% | -$6.4M | 0.02% | 610 |
|
|
2025
Q2 | $18.4M | Sell |
64,090
-3,486
| -5% | -$1.04M | 0.02% | 599 |
|
|
2025
Q1 | $20.8M | Buy |
67,576
+33,254
| +97% | +$11.4M | 0.03% | 553 |
|
|
2024
Q4 | $12.1M | Sell |
34,322
-15,877
| -32% | -$5.84M | 0.02% | 693 |
|
|
2024
Q3 | $18M | Buy |
50,199
+5,231
| +12% | +$1.77M | 0.03% | 569 |
|
|
2024
Q2 | $14.3M | Buy |
44,968
+11,503
| +34% | +$3.04M | 0.02% | 603 |
|
|
2024
Q1 | $7.69M | Buy |
33,465
+3,198
| +11% | +$722K | 0.01% | 727 |
|
|
2023
Q4 | $6.66M | Buy |
30,267
+2,409
| +9% | +$555K | 0.01% | 820 |
|
|
2023
Q3 | $6.29M | Sell |
27,858
-12,900
| -32% | -$2.97M | 0.01% | 900 |
|
|
2023
Q2 | $9M | Sell |
40,758
-200,626
| -83% | -$44.4M | 0.02% | 678 |
|
|
2023
Q1 | $54.1M | Buy |
241,384
+50,888
| +27% | +$12.5M | 0.1% | 209 |
|
|
2022
Q4 | $53M | Sell |
190,496
-25,060
| -12% | -$6.33M | 0.1% | 198 |
|
|
2022
Q3 | $45.1M | Buy |
215,556
+12,425
| +6% | +$2.78M | 0.09% | 222 |
|
|
2022
Q2 | $47.9M | Buy |
203,131
+27,922
| +16% | +$5.68M | 0.05% | 404 |
|
|
2022
Q1 | $31.4M | Sell |
175,209
-90,029
| -34% | -$17.2M | 0.02% | 599 |
|
|
2021
Q4 | $57.3M | Buy |
265,238
+93,847
| +55% | +$18.4M | 0.04% | 444 |
|
|
2021
Q3 | $31.6M | Buy |
171,391
+66,474
| +63% | +$13.1M | 0.02% | 572 |
|
|
2021
Q2 | $18.8M | Buy |
104,917
+56,599
| +117% | +$10.8M | 0.02% | 665 |
|
|
2021
Q1 | $8.08M | Buy |
48,318
+26,830
| +125% | +$4.47M | 0.01% | 899 |
|
|
2020
Q4 | $3.26M | Sell |
21,488
-2,867
| -12% | -$376K | ﹤0.01% | 1174 |
|
|
2020
Q3 | $2.46M | Sell |
24,355
-21,232
| -47% | -$2.33M | ﹤0.01% | 1187 |
|
|
2020
Q2 | $5.52M | Sell |
45,587
-3,893
| -8% | -$438K | 0.01% | 1165 |
|
|
2020
Q1 | $4.69M | Buy |
49,480
+23,316
| +89% | +$2.22M | 0.01% | 1189 |
|
|
2019
Q4 | $2.31M | Buy |
26,164
+5,235
| +25% | +$461K | ﹤0.01% | 1805 |
|
|
2019
Q3 | $1.67M | Sell |
20,929
-73,552
| -78% | -$5.92M | ﹤0.01% | 1907 |
|
|
2019
Q2 | $7.38M | Sell |
94,481
-11,087
| -11% | -$1.04M | 0.01% | 1324 |
|
|
2019
Q1 | $12.4M | Sell |
105,568
-2,437
| -2% | -$284K | 0.01% | 1024 |
|
|
2018
Q4 | $11.8M | Buy |
108,005
+6,657
| +7% | +$772K | 0.01% | 1036 |
|
|
2018
Q3 | $13M | Buy |
101,348
+63,664
| +169% | +$7.87M | 0.01% | 1137 |
|
|
2018
Q2 | $4.26M | Sell |
37,684
-3,049
| -7% | -$335K | ﹤0.01% | 1597 |
|
|
2018
Q1 | $4.58M | Buy |
40,733
+420
| +1% | +$53.4K | ﹤0.01% | 1572 |
|
|
2017
Q4 | $5.96M | Sell |
40,313
-43,751
| -52% | -$5.56M | ﹤0.01% | 1549 |
|
|
2017
Q3 | $9.85M | Sell |
84,064
-3,357
| -4% | -$429K | 0.01% | 1333 |
|
|
2017
Q2 | $11.4M | Sell |
87,421
-6,816
| -7% | -$850K | 0.01% | 1261 |
|
|
2017
Q1 | $12.8M | Sell |
94,237
-2,662
| -3% | -$403K | 0.01% | 1229 |
|
|
2016
Q4 | $13.9M | Sell |
96,899
-9,621
| -9% | -$1.23M | 0.01% | 1207 |
|
|
2016
Q3 | $12.4M | Sell |
106,520
-33,775
| -24% | -$4.06M | 0.01% | 1221 |
|
|
2016
Q2 | $14.9M | Sell |
140,295
-36,326
| -21% | -$4.05M | 0.02% | 1057 |
|
|
2016
Q1 | $19.7M | Sell |
176,621
-5,767
| -3% | -$730K | 0.02% | 792 |
|
|
2015
Q4 | $28.7M | Sell |
182,388
-42,518
| -19% | -$6.19M | 0.03% | 589 |
|
|
2015
Q3 | $29.5M | Sell |
224,906
-185
| -0.1% | -$29.7K | 0.04% | 564 |
|
|
2015
Q2 | $39.2M | Sell |
225,091
-60,243
| -21% | -$10.8M | 0.04% | 522 |
|
|
2015
Q1 | $49.2M | Sell |
285,334
-138,215
| -33% | -$21.1M | 0.06% | 370 |
|
|
2014
Q4 | $54.8M | Sell |
423,549
-100,215
| -19% | -$12.9M | 0.06% | 358 |
|
|
2014
Q3 | $67.4M | Buy |
523,764
+43,219
| +9% | +$4.46M | 0.08% | 290 |
|
|
2014
Q2 | $42.5M | Buy |
480,545
+161,311
| +51% | +$15.5M | 0.05% | 373 |
|
|
2014
Q1 | $30M | Buy |
319,234
+37,049
| +13% | +$3.79M | 0.04% | 453 |
|
|
2013
Q4 | $31.9M | Buy |
282,185
+216,655
| +331% | +$19.5M | 0.04% | 437 |
|
|
2013
Q3 | $5.17M | Sell |
65,530
-17,300
| -21% | -$1.26M | 0.01% | 911 |
|
|
2013
Q2 | $5.45M | Buy |
+82,830
| New | +$5.34M | 0.01% | 864 |
|
Other funds holding UTHR
ACA
JT
Allianz Asset Management's UTHR Position: Q2 2026 in Review
Allianz Asset Management increased its United Therapeutics (UTHR) stake by 28% in Q2 2026, buying an estimated $6.02M and bringing the position to 48,445 shares worth $26.7M. The position accounts for 0.02% of the portfolio, ranked #616.
Allianz Asset Management first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.4M in Q3 2014. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Allianz Asset Management held 48,445 shares of United Therapeutics worth $26.7M as of Q2 2026.
- Allianz Asset Management bought 10,697 United Therapeutics shares in Q2 2026, an estimated $6.02M.
- United Therapeutics made up 0.02% of Allianz Asset Management's portfolio in Q2 2026, its #616 holding.
- Allianz Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Allianz Asset Management's United Therapeutics position peaked at $67.4M in Q3 2014.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.